from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1336/cysM

LFCtreatmentdescriptionclass of inhibitor

-1.994

Amikacinug/mL Amikacintranslation

-0.924

Cap5-10ug/mL Capreomycintranslation

-0.917

Rox10-50 ug/mL Roxithromycintranslation

-0.359

SM2-5 ug/mL Streptomycintranslation

-2.443

Tet5-10 ug/mL Tetracyclinetranslation

-1.739

Rif0.2-5ug/mL Rifampicintranscription

-0.259

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.552

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.591

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.280

CPZ10-50 ug/mL Chlorpromazinerespiration

0.526

Clofazimine10-13 ug/mL Clofaziminerespiration

0.099

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.023

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.441

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.252

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.083

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.191

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.255

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.180

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.111

KCN5-20 ug/mL Potassium cyaniderespiration

-2.911

NaN30.2-2 mM Sodium aziderespiration

-1.186

Nigericin50 uM Nigericinrespiration

-0.265

TRC10-150 ug/mL Triclosanrespiration

0.070

TRZ10-25 ug/mL Thioridazinerespiration

-1.575

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.481

menadione6-10 ug/mL Menadionerespiration

0.189

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.081

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.323

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.539

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.453

NRP_1Non-replicating persistence stage 1dosRassociated

0.466

Amp0.2mg/mL AmpicillincellWall

-0.008

Cephalexin20-100 ug/mL CephalexincellWall

0.013

Cerulenin0.32-5 ug/mL CerulenincellWall

0.261

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.173

EMB10-20 ug/mL EthambutolcellWall

0.522

Eta12-40 ug/mL EthionamidecellWall

0.267

INH0.2-0.4 ug/mL IsoniazidcellWall

0.579

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.336

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.027

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.001

BZA0.12 mg/mL BenzamidearomaticAmides

0.251

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.749

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.190

H2O24 mM hydrogen peroxideDNAdamaging

-0.446

Levo10 ug/mL LevofloxacinDNAdamaging

0.347

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.646

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.333

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.072

UVUV-irradiationDNAdamaging

0.550

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.104

Antimycin12.5-50 ug/mL Antimycin A?

-0.395

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.234

PA_110-50 ug/mL Antitubercular compound PA-1?

0.158

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.428

PA8240.2-2 ug/mL PA-824?

0.451

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.634

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.611

Verapamil50 uM Verapamil?

-0.686

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.893

methoxatin10-20 ug/mL Methoxatin?